Innovative and Collaborative Design Sets the Stage for Life Science Innovation
17 Jun 2022
It is a thrilling time to be in the life sciences. Investment and employment in this sector have seen unprecedented gains, especially since the outbreak of the COVID-19 pandemic. At the same time, the speed of innovation has accelerated, as demonstrated by the rapid development and production of mRNA COVID-19 vaccines, to name just one. Of course, there are a host of other medical conditions — ranging from neurological conditions, heart disease, and cancer to Alzheimer’s disease and diabetes — that require the attention and best efforts of life science innovators. These forces have thrown a spotlight on this critical American industry as never before.